HAPSTR2 Inhibitors
HAPSTR2 inhibitors encompass a diverse array of compounds that interact with various cellular signaling pathways, ultimately leading to a decrease in HAPSTR2 activity. Kinase inhibitors such as those affecting multiple kinases, or those selectively targeting PI3K, MEK1/2, p38 MAP kinase, or JNK, play a pivotal role in modulating cellular phosphorylation states and stress response pathways that are crucial for HAPSTR2 functionality. When these kinases are inhibited, the resulting altered phosphorylation landscape impacts the stress signaling pathways, leading to a reduction in HAPSTR2 activity. Additionally, inhibition of mTOR signaling by specific compounds has a profound effect on the cell survival and growth pathways that HAPSTR2 is associated with, subsequently decreasing its activity.
Further diminishing the activity of HAPSTR2 are inhibitors that disrupt proteostasis and vesicle trafficking, as well as those affecting protein kinase C and N-linked glycosylation. For instance, proteasome inhibition hinders the degradation of ubiquitinated proteins, thereby indirectly influencing HAPSTR2 by perturbing the cellular stress responses it modulates. Similarly, the inhibition of ADP-ribosylation factor by certain compounds leads to disruption in vesicle trafficking, which in turn can affect the intracellular signaling critical for HAPSTR2's role in stress responses. Moreover, compounds that selectively inhibit protein kinase C can result in the disturbance of PKC-mediated signaling events that HAPSTR2 may regulate. Lastly, agents that prevent proper protein glycosylation can induce endoplasmic reticulum stress, thereby challenging the protein folding environment and indirectly reducing HAPSTR2 function through compromised cellular stress response pathways.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that disrupts multiple signaling pathways, leading to altered phosphorylation states within the cell. This can indirectly inhibit HAPSTR2 activity by altering the phosphorylation-dependent signaling it is involved in. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A phosphoinositide 3-kinases (PI3K) inhibitor that impedes the PI3K/AKT pathway. Through this action, it can indirectly inhibit HAPSTR2 by impacting downstream signaling events reliant on this pathway for stress response modulation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
An inhibitor of p38 MAP kinase which is involved in cellular stress responses. By inhibiting p38 MAP kinase, SB 203580 indirectly decreases HAPSTR2 functionality by altering the stress response signaling pathways HAPSTR2 is associated with. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A selective inhibitor of MEK1/2 which in turn affects the ERK pathway. As HAPSTR2 is associated with stress response pathways, inhibiting MEK1/2 disrupts the signaling that could indirectly decrease HAPSTR2's activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), which is another stress-activated protein kinase. By inhibiting JNK, SP 600125 indirectly influences HAPSTR2 activity by modulating the stress response pathways it is associated with. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
This compound acts as an inhibitor of PI3K, leading to disruption of the PI3K/AKT pathway which is a critical regulator of cell survival and stress responses, thus indirectly affecting HAPSTR2 activity linked to these pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A selective inhibitor of MEK, which is upstream of ERK in the MAPK pathway. HAPSTR2, being involved in stress response signaling, can have its activity indirectly reduced by PD 98059 through the attenuation of MAPK pathway signaling. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
A proteasome inhibitor that prevents the degradation of ubiquitinated proteins. By disrupting proteostasis, lactacystin can indirectly inhibit HAPSTR2 by altering the cellular stress response mechanisms it modulates. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor which impacts cell growth and survival pathways. As HAPSTR2 is implicated in cellular stress responses, rapamycin can indirectly inhibit its activity by altering the mTOR signaling pathway. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
A selective inhibitor of protein kinase C (PKC). HAPSTR2's activity can be indirectly inhibited by this compound through the disruption of PKC-mediated signaling pathways involved in cellular stress responses. | ||||||